Biocytogen: Innovative Models to Empower Antibody Discovery
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities. Powered by cutting-edge gene editing technologies and a state-of-the-art animal facility, Biocytogen developed a seamlessly integrated platform for efficient antibody drug discovery and validation, including animal model generation, therapeutic antibody discovery (via RenMab™ Mouse), and in vivo/in vitro preclinical validation studies. Biocytogen collaborates with top pharmaceutical and biotechnology companies worldwide. Together, we discover innovative medicines for a better, healthier world.
At Biocytogen, we have over 1200 genetically modified strains of BioMice that have assisted many of the top pharmaceutical companies with their R&D projects.
- Advance life sciences with high-quality and customized models to push the boundary of utilization of humanized target models in biomedical research
- Develop technological platforms to accelerate next-generation drug discovery and development
- Empower scientists in drug discovery by providing the necessary expertise to eliminate bottlenecks in research
- Be a global leader in providing seamless preclinical services to our clients